NEW YORK (GenomeWeb News) - Elizabeth Blackburn, Carol Greider, and Jack Szostack this week each won one-third of the Nobel Prize for Medicine 2009 for their discovery of how chromosomes are protected by telomeres and the enzyme telomerase. Greider is a professor and director of Molecular Biology and Genetics in the Johns Hopkins Institute for Basic Biomedical Sciences. Blackburn is a professor of biochemistry and biophysics at the University of California, Berkeley. Szostack is a professor of genetics at Harvard Medical School.
GeneLink BioSciences has tapped Doug Boyle to serve on its board of directors, where he will serve on the audit committee. Boyle is president of Empirical Healthcare Consulting, and he has more than 17 years experience in health care as a financial and operational executive, including leading revenue operations for Quest Diagnostics.
Xenomics has named Bruce Huebner its CEO and board director. The company also said this week that it plans to change the company name to TrovaGene. Huebner has previously served as executive VP and COO at Gen-Probe, and he was president and COO at Nanogen. He also is a former president of Osmetech.
Samuel Levy has joined Scripps Health's genomic medicine program as director of genomic sciences. Levy was director and professor in human genomics at the J. Craig Venter Institute and he was a senior scientist at Celera. At Scripps, he will direct the human genome sequencing research at the Scripps Translational Sciences Institute.
Louis Lange has been named chairman of the board of directors at CardioDx. Lang founded CV Therapeutics, where he was chairman and CEO between 1992 and 2009, when it was bought by Gilead, and he was chief of cardiology and a professor at Jewish Hospital.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People in the News, a weekly roundup of industry comings and goings.